2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk / F. Mach, C. Baigent, A.L. Catapano, K.C. Koskinas, M. Casula, L. Badimon, M.J. Chapman, G.G. De Backer, V. Delgado, B.A. Ference, I.M. Graham, A. Halliday, U. Landmesser, B. Mihaylova, T.R. Pedersen, G. Riccardi, D.J. Richter, M.S. Sabatine, M.-. Taskinen, L. Tokgozoglu, O. Wiklund. - In: EUROPEAN HEART JOURNAL. - ISSN 1522-9645. - 41:1(2020), pp. 111-188. [10.1093/eurheartj/ehz455]

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk

A.L. Catapano
Co-primo
;
M. Casula;
2020

Guidelines; apolipoprotein B; cholesterol; dyslipidaemias; familial hypercholesterolaemia; high-density lipoproteins; lipoprotein remnants; lipoprotein(a); low-density lipoproteins; total cardiovascular risk; treatment (adherence); treatment (drugs); treatment (lifestyle); triglycerides; very low-density lipoproteins
Settore BIO/14 - Farmacologia
2020
Article (author)
File in questo prodotto:
File Dimensione Formato  
European Heart Journal 2020_41_ 111.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 2.47 MB
Formato Adobe PDF
2.47 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/706264
Citazioni
  • ???jsp.display-item.citation.pmc??? 2261
  • Scopus 5150
  • ???jsp.display-item.citation.isi??? 2557
social impact